Cryptosporidiosis: A global threat to human and animal health.
Gespeichert in:
| Titel: | Cryptosporidiosis: A global threat to human and animal health. |
|---|---|
| Autoren: | Widodo, Wimbuh Tri1 wimbuh.tri@pasca.unair.ac.id, Khairullah, Aswin Rafif2, Pratama, Bima Putra3, Ambarika, Rahmania4, Furqoni, Abdul Hadi5,6, Kristianto, Sonny1, Wardhani, Bantari Wisynu Kusuma7,8, Widoretno, Widoretno5, Khariri, Khariri5, Hermawati, Luluk9, Suri, Auliyani Andam10, Moses, Ikechukwu Benjamin11, Putri, Alifiani Kartika12, Kurniasih, Dea Anita Ariani13, Maha, Masri Sembiring5, Khalisa, Andi Thafida8, Ahmad, Riza Zainuddin2, Wibow, Syahputra14 |
| Quelle: | Open Veterinary Journal. 2025, Vol. 15 Issue 10, p4814-4833. 20p. |
| Publikationsart: | Abstract |
| Schlagworte: | Cryptosporidiosis, Cryptosporidium, Public health, Preventive medicine, Zoonoses, Immune response, Animal health, Sanitation |
| Geografische Kategorien: | Africa |
| Author-Supplied Keywords: | Diarrhea Immunity Oocyst Parasite Prevention |
| Abstract: | Cryptosporidiosis is a significant zoonotic illness that infects both humans and animals. The protozoan parasite that causes this illness is a member of the genus Cryptosporidium, a eukaryote in the phylum Apicomplexa. The parasite Cryptosporidium is monoxenic, meaning it has only one host. Oocyte-to-oocyte development occurs in the host organism without an intermediate host. Developing nations have a far greater prevalence of Cryptosporidium infections because many people there still lack access to basic sanitation and clean water. Both innate and adaptive immune system components are involved in the host immunological response to Cryptosporidium infection; both pathways contribute to the defense against Cryptosporidiosis. Globally, cryptosporidiosis is estimated to cause tens of millions of cases each year, with a prevalence of 10%–20% among children under five in sub-Saharan Africa and South Asia, whereas approximately 750,000 cases occur annually in the United States. The disease is more common in developing countries due to limited access to safe water and sanitation. Cryptosporidium can be detected in the digestive tract, lungs, and conjunctiva; however, the intestines are most susceptible to cryptosporidiosis. Nowadays, most people agree that Cryptosporidium is a frequent parasite that causes diarrheal illness. Furthermore, infections caused by Cryptosporidium have spread to humans, primarily affecting individuals with immunological problems, such as those with AIDS. Cryptosporidiosis is typically diagnosed by looking for parasite eggs, oocyte antigen, or oocyte DNA in stool samples. Consuming food or beverages containing the oocysts of these protozoa can infect both humans and animals. Most diseased individuals and animals with robust immune systems can heal themselves without medical intervention. The main strategy for preventing cryptosporidiosis is to reduce or eradicate environmental contamination with infectious oocysts, as there is currently no effective treatment for the disease. [ABSTRACT FROM AUTHOR] |
| Copyright of Open Veterinary Journal is the property of Open Veterinary Journal and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Author Affiliations: | 1Master of Forensic Science, Postgraduate School, Universitas Airlangga, Surabaya, Indonesia. 2Research Center for Veterinary Science, National Research and Innovation Agency (BRIN), Bogor, Indonesia. 3Research Center for Agroindustry, National Research and Innovation Agency (BRIN), South Tangerang, Indonesia. 4Universitas Strada Indonesia, Kediri, Indonesia. 5Center for Biomedical Research, National Research and Innovation Agency (BRIN), Bogor, West Java, Indonesia. 6Research Center on Global Emerging and Re-Emerging Infectious Diseases, Institute of Tropical Disease, Universitas Airlangga, Surabaya, Indonesia. 7Research Center for Pharmaceutical Ingredients and Traditional Medicine, National Research and Innovation Agency (BRIN), Bogor, Indonesia. 8Faculty of Military Pharmacy, Universitas Pertahanan, Bogor, Indonesia. 9Department of Molecular Biology, Faculty of Medicine and Health Sciences, Universitas Sultan Ageng Tirtayasa, Banten, Indonesia. 10Departement of Physiology, Faculty of Medicine, UIN Syarif Hidayatullah Jakarta, Banten, Indonesia. 11Department of Applied Microbiology, Faculty of Science, Ebonyi State University, Abakaliki, Nigeria. 12Muhammadiyah Hospital Tuban, Tuban, Indonesia. 13Research Center for Public Health and Nutrition, National Research and Innovation Agency (BRIN), Bogor, Indonesia. 14Eijkman Research Center for Molecular Biology, National Research and Innovation Agency (BRIN), Bogor, Indonesia. |
| ISSN: | 2226-4485 |
| DOI: | 10.5455/OVJ.2025.v15.i10.3 |
| Dokumentencode: | 190365264 |
| Datenbank: | Veterinary Source |
Schreiben Sie den ersten Kommentar!